These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 5536379)

  • 1. [Symptom genesis and therapy of travel sickness. Experimentally produced motion sicknesses and the effect of dimenhydrate (Novomina)].
    von Lieven T
    Munch Med Wochenschr; 1970 Oct; 112(43):1953-9. PubMed ID: 5536379
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness.
    Muth ER; Jokerst M; Stern RM; Koch KL
    Aviat Space Environ Med; 1995 Nov; 66(11):1041-5. PubMed ID: 8588792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Progress in the therapy of motion sickness: the dimenhydrinate-containing chewing gum dragee].
    Reimann HJ; Erbel F; Bergemann B
    Ther Ggw; 1981 Dec; 120(12):1171-80. PubMed ID: 7330785
    [No Abstract]   [Full Text] [Related]  

  • 4. High dose ondansetron for reducing motion sickness in highly susceptible subjects.
    Muth ER; Elkins AN
    Aviat Space Environ Med; 2007 Jul; 78(7):686-92. PubMed ID: 17679566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug effectiveness on experimental optokinetic and vestibular motion sickness.
    Brandt T; Dichgans J; Wagner W
    Aerosp Med; 1974 Nov; 45(11):1291-7. PubMed ID: 4611183
    [No Abstract]   [Full Text] [Related]  

  • 6. The laboratory assessment of anti-motion sickness and anti-vertigo drugs.
    Barber HO; Basser W; Johnson WH; Takahashi P
    Can Med Assoc J; 1967 Dec; 97(24):1460-5. PubMed ID: 4863013
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative studies on the effect of two antimetics in experimental kinetoses].
    von Lieven T; Voigt K
    Med Klin; 1971 Aug; 66(32):1089-93. PubMed ID: 5562100
    [No Abstract]   [Full Text] [Related]  

  • 8. The spiral after effect (SAE) as a measure of motion sickness susceptibility and the effect on the SAE of an antimotion sickness drug and a central nervous system depressant.
    Croucher T; Hindmarch I
    Psychopharmacologia; 1973 Sep; 32(3):215-22. PubMed ID: 4762231
    [No Abstract]   [Full Text] [Related]  

  • 9. Transdermal therapeutic system scopolamine (TTSS), dimenhydrinate, and placebo--a comparative study at sea.
    Noy S; Shapira S; Zilbiger A; Ribak J
    Aviat Space Environ Med; 1984 Nov; 55(11):1051-4. PubMed ID: 6508687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phenytoin on vection-induced motion sickness and gastric myoelectric activity.
    Stern RM; Uijtdehaage SH; Muth ER; Koch KL
    Aviat Space Environ Med; 1994 Jun; 65(6):518-21. PubMed ID: 8074624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of marezine and dramamine in preventing symptoms of motion sickness.
    Weinstein SE; Stern RM
    Aviat Space Environ Med; 1997 Oct; 68(10):890-4. PubMed ID: 9327113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Electroencephalographic studies on a dimenhydrinate in a chewing-gum for motion sickness].
    Reimann HJ; Erbel F
    Ther Ggw; 1981 Sep; 120(9):837-44. PubMed ID: 7292363
    [No Abstract]   [Full Text] [Related]  

  • 13. Motion-sickness medications for aircrew: impact on psychomotor performance.
    Paul MA; MacLellan M; Gray G
    Aviat Space Environ Med; 2005 Jun; 76(6):560-5. PubMed ID: 15945400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diazepam as an anti-motion sickness drug.
    McClure JA; Lycett P; Baskerville JC
    J Otolaryngol; 1982 Aug; 11(4):253-9. PubMed ID: 7131636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gender of subjects and experimenter on susceptibility to motion sickness.
    Jokerst MD; Gatto M; Fazio R; Gianaros PJ; Stern RM; Koch KL
    Aviat Space Environ Med; 1999 Oct; 70(10):962-5. PubMed ID: 10519473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectivity of antimotion sickness drugs during artificial gravity simulations.
    Green JA
    Aerosp Med; 1973 Nov; 44(11):1255-60. PubMed ID: 4586812
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of some effects of three antimotion sickness drugs on nystagmic responses to angular accelerations and to optokinetic stimuli.
    Collins WE; Schroeder DJ; Elam GW
    Aviat Space Environ Med; 1982 Dec; 53(12):1182-9. PubMed ID: 7159338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin for motion sickness: clinical evaluation.
    Knox GW; Woodard D; Chelen W; Ferguson R; Johnson L
    Laryngoscope; 1994 Aug; 104(8 Pt 1):935-9. PubMed ID: 8052077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement on motion sickness.
    Committee to Advise on Tropical Medicine and Travel
    Can Commun Dis Rep; 2003 Nov; 29():1-12. PubMed ID: 14655530
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness.
    Levine ME; Chillas JC; Stern RM; Knox GW
    Aviat Space Environ Med; 2000 Nov; 71(11):1111-4. PubMed ID: 11086664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.